Reply
Authors:
- 12 June 2026
- journal article
- Published by Elsevier in Ophthalmology
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Ocular Adverse Events With SemaglutideJAMA Ophthalmology, 2025
- Semaglutide and Cardiovascular Outcomes in Obesity without DiabetesNew England Journal of Medicine, 2023
- Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trialThe Lancet Diabetes & Endocrinology, 2019
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2019
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2016